FRM
KROS icon

Fox Run Management’s Keros Therapeutics KROS Stock Holding History

Fox Run Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$165K Sell
12,354
-6,635
-35% -$88.6K 0.03% 771
2025
Q1 		$193K Sell
18,989
-3,224
-15% -$32.9K 0.03% 803
2024
Q4 		$352K Buy
22,213
+16,069
+262% +$254K 0.06% 568
2024
Q3 		$357K Buy
+6,144
New +$357K 0.08% 485